Peri-Device Leaks after Percutaneous Left Atrial Appendage Closure: Clinical Significance and Unmet Diagnostic Needs

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 5.1K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

David R. Holmes, Vivek Y. Reddy, Zoltan G. Turi et al. · The Lancet · 2009 · 2.2K citations

Medicine, Cardiology, Pharmacotherapy +15